Both in Pharmaceuticals

Matinas BioPharma Holdings vs Valion Bio

Over the past year MTNB returned −45.6% and VBIO returned −75.7%; their daily moves had a correlation of -0.01.

MTNB −45.6% VBIO −75.7%Growth of $1, one year, split-adjusted
MetricMTNBVBIO
Price$1.51$0.5500
Market cap$1.5M$1.2M
Today−20.53%−10.83%
1 month−37.6%−78.1%
6 months−85.6%—
Year to date−82.8%—
1 year−92.5%—
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales——
Net cash$755.0K-$5.3M
Dividend yield——
Volatility (60d)775.0%—
Short % of float0.5%9.4%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).